CCL14 Antibodies

Santa Cruz Biotechnology delivers a wide array of CCL14 monoclonal antibodies for research focused on understanding CCL14's role in various biological processes. CCL14 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CCL14, also known as chemokine (C-C motif) ligand 14, plays an essential role in the immune response by recruiting immune cells to inflammation sites. CCL14 has been linked to various physiological and pathological processes, including tissue repair, cancer progression, and autoimmune diseases. Research into CCL14 functions continues to reveal new insights about immune system dynamics. Understanding CCL14's mechanisms of action is vital for developing targeted therapies. CCL14 research has significant implications for advancing treatments in cancer and inflammatory conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to immunology research and therapeutic development.